L. Moreira

Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease.

M. Teixeira, J. Nicoli, R. Arantes, 2015, Beneficial microbes.

KCNQ and KCNE Isoform-Dependent Pharmacology Rationalizes Native American Dual Use of Specific Plants as Both Analgesics and Gastrointestinal Therapeutics

K. Tran, G. Abbott, R. Yoshimura, 2021, Frontiers in Physiology.

Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.

M. Neves, J. Nicoli, F. S. Martins, 2016, Beneficial microbes.